Fungal pneumonias.
Saubolle MA.
Semin Respir Infect. 2000 Jun;15(2):162-77. doi: 10.1053/srin.2000.9598.
AWMF mold guideline "Medical clinical diagnostics for indoor mold exposure" - Update 2023 AWMF Register No. 161/001.
Hurraß J, Heinzow B, Walser-Reichenbach S, Aurbach U, Becker S, Bellmann R, Bergmann KC, Cornely OA, Engelhart S, Fischer G, Gabrio T, Herr CEW, Joest M, Karagiannidis C, Klimek L, Köberle M, Kolk A, Lichtnecker H, Lob-Corzilius T, Mülleneisen N, Nowak D, Rabe U, Raulf M, Steinmann J, Steiß JO, Stemler J, Umpfenbach U, Valtanen K, Werchan B, Willinger B, Wiesmüller GA.
Allergol Select. 2024 May 3;8:90-198. doi: 10.5414/ALX02444E. eCollection 2024.
Endobronchial fungal disease: an under-recognized entity.
Karnak D, Avery RK, Gildea TR, Sahoo D, Mehta AC.
Respiration. 2007;74(1):88-104. doi: 10.1159/000094708. Epub 2006 Jul 20.
Systemic antifungal agents.
Abuhammour W, Habte-Gabr E.
Indian J Pediatr. 2001 Jul;68(7):655-68. doi: 10.1007/BF02752281.
Pulmonary scedosporiosis.
Severo LC, Porto Nda S, Londero AT.
Rev Inst Med Trop Sao Paulo. 1998 Jul-Aug;40(4):241-3. doi: 10.1590/s0036-46651998000400007.
Pseudallescheria boydii infection associated with IgG4-related disease.
Ogawa S, Inoue T, Sugita K.
Eur J Dermatol. 2022 Sep 1;32(5):653-655. doi: 10.1684/ejd.2022.4342.
Non-aspergillus aspergilloma.
Kathuria SK, Rippon J.
Am J Clin Pathol. 1982 Dec;78(6):870-3. doi: 10.1093/ajcp/78.6.870.
[Invasive fungal disease due to Scedosporium, Fusarium and mucorales].
Pemán J, Salavert M.
Rev Iberoam Micol. 2014 Oct-Dec;31(4):242-8. doi: 10.1016/j.riam.2014.05.002. Epub 2014 Jun 21.
Eumicetoma: actualidades y perspectivas.
Arenas R, Vega-Mémije MªE, Rangel-Gamboa L.
Gac Med Mex. 2017;153(7):841-851. doi: 10.24875/GMM.17002917.
Opportunistic filamentous mycoses: aspergillosis, mucormycosis, phaeohyphomycosis and hyalohyphomycosis.
Perusquía-Ortiz AM, Vázquez-González D, Bonifaz A.
J Dtsch Dermatol Ges. 2012 Sep;10(9):611-21; quiz 621-2. doi: 10.1111/j.1610-0387.2012.07994.x.
